In one paragraphArticle in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
13 authors.
Ariel Martinez-ChavezDepartment of Biochemistry and Molecular Biology, McGovern Medical School, University of Texas Health Science Center, Houston, TX, USA.
Larry E WagnerDepartment of Pharmacology and Physiology, University of Rochester, Rochester, NY, USA.
Sundeep MalikDepartment of Pharmacology and Physiology, University of Rochester, Rochester, NY, USA.
Alexander B SeryshevDepartment of Biochemistry and Molecular Biology, McGovern Medical School, University of Texas Health Science Center, Houston, TX, USA.
Matthew L BakerDepartment of Biochemistry and Molecular Biology, McGovern Medical School, University of Texas Health Science Center, Houston, TX, USA.
Irina I SeryshevaDepartment of Biochemistry and Molecular Biology, McGovern Medical School, University of Texas Health Science Center, Houston, TX, USA. irina.i.serysheva@uth.tmc.edu.ORCID http://orcid.org/0000-0001-6266-3422 Funding
ACQUISITION OF HIGH-THROUGHPUT 200 kV CRYO-TEMS10OD032204 · OD · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI SERYSHEVA, IRINA I · 2022 to 2022
$2.0MMechanisms of inositol trisphosphate receptor-mediated calcium signalingR35GM153178 · NIGMS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI Irina I Serysheva · 2024 to 2026
$1.7MDefining architecture of EC coupling machinery in situR21AR082833 · NIAMS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI SERYSHEVA, IRINA I · 2023 to 2024
$372kNIAMS NIH HHS R21 AR082833NIGMS NIH HHS R35 GM153178NIH HHS S10 OD032204U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) R21AR082833U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) R35GM153178U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) R35GM153178-01S1U.S. Department of Health & Human Services | NIH | NIH Office of the Director (OD) S10OD032204
6 · The paper itselfAbstract
Calcium release through inositol 1,4,5-trisphosphate receptors (IP
Indexed as
Cryoelectron MicroscopyInositol 1,4,5-Trisphosphate ReceptorsAdenosine TriphosphateAnimalsBinding SitesCalciumHumansInositol 1,4,5-TrisphosphateModels, MolecularProtein ConformationProtein IsoformsAdenosine TriphosphateCalciumInositol 1,4,5-TrisphosphateInositol 1,4,5-Trisphosphate ReceptorsProtein Isoforms
Identifiers
PMID42637755
PMCPMC13503717
What OpenQuestion holds
Textmetadata
Read underepoch 390